Coronado receives patents for PNT treatment, technology

September 15, 2004

Fountain Hills, AZ-Coronado Industries Inc. announced that it has received patents for its pneumatic trabeculoplasty (PNT) treatment device and procedure in China.

Fountain Hills, AZ-Coronado Industries Inc. announced that it has received patents for its pneumatic trabeculoplasty (PNT) treatment device and procedure in China.

In making the announcement, Coronado's chief executive officer, Richard Smith, said the company had meetings in New York recently with a major Beijing-based facilitator with a view to bringing the device and cost-saving benefits to the Chinese health authorities and establishing distribution in China.

"It represents an enormous market for Coronado's technology, and receipt of the patents marks another big step forward in our international marketing plans," he said in a prepared statement. "Since our meeting last week, we have had a positive response back from principals in both the national health system and the private sector. We are definitely moving forward."

Dr. Sharkey said the company was intent on establishing representation in a number of overseas markets.

"We have already begun shipping products to distributors in Italy, Spain, and Portugal and negotiations are under way to establish further distribution rights in a number of other countries. You may be sure that we shall be looking very closely into the many opportunities that China presents," he said in a prepared statement.